MedTrace Logo

Effects of Resistance Training in Body Composition and Body Image Perception of Women Throughout the Menstrual Cycle

NCT04038463 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2021-10-04

No results posted yet for this study

Summary

The objective of this research study is two-fold, 1) to determine if body composition and body image perception are affected through the different phases of the menstrual cycle, and 2) if an acute session of resistance training can have different effects depending on the menstrual cycle phase.

Conditions

  • Body Image Disturbance

Interventions

BEHAVIORAL

EFP

This intervention will take place on day 4 of the participants' menstrual cycle. This will correspond to the mid-point of the early follicular phase (EFP).

BEHAVIORAL

LFP

The intervention will take place on day 8 of the participants' menstrual cycle. This will correspond to the mid-point of the late follicular phase (LFP).

BEHAVIORAL

ELP

The intervention will take place on day 18 of the participants' menstrual cycle. This will correspond to the mid-point of the early luteal phase (ELP).

BEHAVIORAL

LLP

The intervention will take place on day 25 of the participants' menstrual cycle. This will correspond to the mid-point of the late luteal phase (LLP).

Sponsors & Collaborators

  • Southern Illinois University Edwardsville

    lead OTHER

Principal Investigators

  • Maria Fernandez del Valle, PhD · Southern Illinois University Edwardsville

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2020-03-16
Completion
2020-03-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04038463 on ClinicalTrials.gov